Novo Nordisk said it will offer all doses of Wegovy for $499 a month to patients paying cash, a bid to reach consumers who can’t get the blockbuster drug through insurance.

Novo Nordisk’s new offering follows a model that Eli Lilly launched last ... as good” as those that come from its auto-injector pens, given costs associated with running a pharmacy such ...

Novo Nordisk is introducing a direct-to-patient ... and access to live support. The current savings model for Wegovy via NovoCare will also be updated in the near future for patients who use ...

But are tackling with a model that we created out of an hybrid between the strength of Novo Nordisk and biotech ... like insulin pens. The company’s disease portfolio includes diabetes ...

Eli Lilly is offering vials of its weight-loss drug Zepbound to patients at a discount — but only if they skip their ...

The syringe option is cheaper for consumers: It costs between $349 and $699 a month for the vials compared to a list price of $1,086.37 per monthly injector pen. Wegovy's maker, Novo Nordisk ...